Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 5

Abstract

<b>Objective</b> The clinical distribution and drug resistance of <i>Escherichia coli </i> and<i>Klebsiella pneumoniae </i> in a hospital of Nanjing from 2020 to 2022 were analyzed in order to provide the basis for clinical rational use of antibiotics. <b>Methods</b> The distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae </i> specimens in Zhongda Hospital Southeast University from 2020 to 2022 were retrospectively analyzed.<b>Results</b> A total of 3 507, 4 323 and 4 806 pathogenic bacteria were detected from 2020 to 2022. There were 616, 748 and 840 strains of <i>Escherichia coli </i>, and 456, 631 and 757 strains of <i>Klebsiella pneumoniae </i>, with the total 3-year detection rate of 17.4% and 14.6%. There was a statistically significant difference in the constituent ratio of pathogenic bacteria between 2020 and 2022 (P<0.01). From 2020 to 2022, the top three samples of pathogenic bacteria were sputum, blood and urine. From 2020 to 2022, the drug resistance rates of <i>Escherichia coli </i> to cefepime, ceftriaxone, cefazolin, gentamicin, ciprofloxacin, levofloxacin and compound trimethoprim were significantly different (P<0.01). The drug resistance rates of <i>Klebsiella pneumoniae </i> to imipenem, ertapenem, cefepime, ceftriaxone, cefoperazone sulbactam, cefazolin, cefoxitin, piperacillin tazobactam, ampicillin, amikacin, gentamicin, levofloxacin, nitrofurantoin and compound trimethoprim were significantly different (P<0.01).<b>Conclusion</b> The average detection rate of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> was more than 30% in 2020—2022. The resistance of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> to various antibacterial drugs is statistically different. The clinically targeted drugs need to be selected in strict accordance with the drug sensitivity results.

Authors and Affiliations

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang

Keywords

Related Articles

Research progress of left bundle branch block

Left bundle branch block (LBBB) is an important cause of heart failure. When LBBB occurs, the excitation sequence of the left ventricle changes, leading to the change of cardiac systolic pattern, resulting in cardiac ele...

Comparison of AngioJet thrombectomy system and catheter-directed thrombolysis in treatment of acute lower extremity deep venous thrombosis

"Objective To investigate the treating effects of acute deep venous thrombosis (ADVT) of lower extremity using the AngioJet thrombectomy system compared to catheter-directed thrombolysis (CDT). Methods A total of 30 A...

Effect of blood lactate clearance rate on the prognosis of sepsis patients undergoing continuous renal replacement therapy

Objective To analyze the blood lactate levels and lactate clearance rate in septic patients undergoing continuous renal replacement therapy (CRRT) with different clinical outcomes, and to explore the value of blood lact...

Experimental study on the protection of spinal motoneurons by using glatiramer acetate based on a rat model of nerve stumps

Objective To determine the activation of glial cells after brachial plexus injury (BPI), and to explore whether glatiramer acetate (GA) can improve the survival rate of spinal motoneurons of nerve stumps by inhibiting th...

Study on the protective effect and mechanism of paeonol on myocarditis in sepsis mice

Objective To investigate the protective and anti-inflammatory effects of paeonol (PAE) on lipopolysaccharide (LPS) -induced myocarditis in septic mice. Methods A total of 30 male C57/bl-6 mice were randomly divided int...

Download PDF file
  • EP ID EP736345
  • DOI 10.13429/j.cnki.cjcr.2024.05.025
  • Views 79
  • Downloads 0

How To Cite

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang (2024). Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022. Chinese Journal of Clinical Research, 37(5), -. https://www.europub.co.uk/articles/-A-736345